Breaking News

You are here » Indian-Commodity  :  Top News  :  Maruti Suzuki India sells one lakh units of Baleno in India

04-Oct2016

Maruti Suzuki India sells one lakh units of Baleno in India

Maruti Suzuki India's (MSIL) premium hatchback, Baleno, has crossed a cumulative domestic sale of one lakh units on October 4, 2016. Baleno, launched in Oct 2015, is one of the top selling models for Maruti Suzuki and has emerged as the leading premium hatchback in India. In addition to domestic sales, 33,800 Baleno cars have been exported across the world, including to Japan and Europe.

Baleno has gained popularity for its innovative styling, spacious interiors and class-leading features, the superior ride and handling, safety and fuel efficiency have added to its appeal among customers. All Baleno customers have received their cars through NEXA, the new retail experience offered by Maruti Suzuki.

Maruti Suzuki is an India-based company engaged in the manufacture, purchase and sale of motor vehicles, components and spare parts (automobiles).


Related News

View all news

Crude oil futures end higher on Friday

Crude oil futures ended higher on Friday on worries about possible impact of US sanctions on Iran's oil exports on crude supply in the market coupled with potential US-Saudi tensions. Prices also supported......

Crude oil futures extend losses on Thursday

Extending previous session losses, crude oil futures ended lower on Thursday due to a sharp jump in US crude inventories last week and on demand growth concerns. The Energy Information Administration's......

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......